Withdrawing renin-angiotensin inhibitors/angiotensin receptor-neprilysin inhibitors and mineralocorticoid receptor antagonists tied to higher one-year mortality, morbidity.
The therapeutic approach was safe, but the study did not meet its primary efficacy outcome using the six-minute walking test.
Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...
Based on the Phase II data, Imbria Pharmaceuticals’ inerafaxstat could complement existing treatments rather than replace ...
While everybody's heart has an absolute chronological age (as old as that person is), hearts also have a theoretical ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...
New data show the machine learning algorithms may be used to detect PCWP elevation, aiding in assessment of heart failure with preserved ejection ...
BioCardia (BCDA) announced two-year outcomes from the double-blind randomized placebo-controlled Phase 3 CardiAMP-HF study of its CardiAMP ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback